122 related articles for article (PubMed ID: 31735335)
1. Upregulated PTPN2 induced by inflammatory response or oxidative stress stimulates the progression of thyroid cancer.
Zhang Z; Xu T; Qin W; Huang B; Chen W; Li S; Li J
Biochem Biophys Res Commun; 2020 Jan; 522(1):21-25. PubMed ID: 31735335
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory response or oxidative stress induces upregulation of PTPN2 and thus promotes the progression of laryngocarcinoma.
Yang HJ; Yu G; Wang Y; Guo X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4314-4319. PubMed ID: 32373968
[TBL] [Abstract][Full Text] [Related]
3. PTPN2 induced by inflammatory response and oxidative stress contributed to glioma progression.
Wu L; Wang F; Xu J; Chen Z
J Cell Biochem; 2019 Nov; 120(11):19044-19051. PubMed ID: 31241223
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in
Sharp RC; Beg SA; Naser SA
Front Cell Infect Microbiol; 2018; 8():11. PubMed ID: 29423382
[TBL] [Abstract][Full Text] [Related]
5. A cell type-specific role of protein tyrosine phosphatase non-receptor type 2 in regulating ER stress signalling.
Kasper SH; Spalinger MR; Raselli T; Scharl M
Digestion; 2015; 91(3):248-56. PubMed ID: 25823847
[TBL] [Abstract][Full Text] [Related]
6. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
Veenstra C; Karlsson E; Mirwani SM; Nordenskjöld B; Fornander T; Pérez-Tenorio G; Stål O
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1845-1856. PubMed ID: 31025094
[TBL] [Abstract][Full Text] [Related]
7. A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2).
Duval R; Bui LC; Berthelet J; Dairou J; Mathieu C; Guidez F; Dupret JM; Cools J; Chomienne C; Rodrigues-Lima F
Sci Rep; 2015 Jun; 5():10750. PubMed ID: 26040922
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death.
Roca-Rivada A; Marín-Cañas S; Colli ML; Vinci C; Sawatani T; Marselli L; Cnop M; Marchetti P; Eizirik DL
Diabetologia; 2023 Aug; 66(8):1544-1556. PubMed ID: 36988639
[TBL] [Abstract][Full Text] [Related]
10. PTPN2 Regulates the Interferon Signaling and Endoplasmic Reticulum Stress Response in Pancreatic β-Cells in Autoimmune Diabetes.
Elvira B; Vandenbempt V; Bauzá-Martinez J; Crutzen R; Negueruela J; Ibrahim H; Winder ML; Brahma MK; Vekeriotaite B; Martens PJ; Singh SP; Rossello F; Lybaert P; Otonkoski T; Gysemans C; Wu W; Gurzov EN
Diabetes; 2022 Apr; 71(4):653-668. PubMed ID: 35044456
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
Spalinger MR; McCole DF; Rogler G; Scharl M
World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin D
Zhang P; Zhang W; Zhang D; Wang M; Aprecio R; Ji N; Mohamed O; Li Y; Ding Y; Wang Q
J Periodontal Res; 2018 Jun; 53(3):467-477. PubMed ID: 29516520
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase non-receptor Type 2 regulates IFN-γ-induced cytokine signaling in THP-1 monocytes.
Scharl M; Hruz P; McCole DF
Inflamm Bowel Dis; 2010 Dec; 16(12):2055-64. PubMed ID: 20848498
[TBL] [Abstract][Full Text] [Related]
15. Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase.
Ha Thi HT; Choi SW; Kim YM; Kim HY; Hong S
PLoS One; 2016; 11(9):e0162724. PubMed ID: 27611995
[TBL] [Abstract][Full Text] [Related]
16. Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
Karlsson E; Veenstra C; Emin S; Dutta C; Pérez-Tenorio G; Nordenskjöld B; Fornander T; Stål O
Breast Cancer Res Treat; 2015 Aug; 153(1):31-40. PubMed ID: 26208487
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PTPN2 in Visceral Adipose Tissue Ameliorated Atherosclerosis via T Cells Polarization Shift in Diabetic Apoe-/- Mice.
Li Y; Zhou H; Wang F; Han L; Liu M; Li Y; Wang Z; Tang M; Zhang W; Zhong M
Cell Physiol Biochem; 2018; 46(1):118-132. PubMed ID: 29587266
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
[TBL] [Abstract][Full Text] [Related]
19. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.
Song J; Lan J; Tang J; Luo N
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077422
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic variations in PTPN2 and CD122 with ocular Behcet's disease.
Zhang Q; Li H; Hou S; Yu H; Su G; Deng B; Qi J; Zhou C; Kijlstra A; Yang P
Br J Ophthalmol; 2018 Jul; 102(7):996-1002. PubMed ID: 29502070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
